Methods for neuroprotection
US5554601A · kind A · utility
41Cited by
1References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 1994 |
| Grant date | Sep 10, 1996 |
| Priority date | — |
| Expiry date | Oct 4, 2014 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB82Y5/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided for conferring neuroprotection on a population of cells using estrogen compounds that have insubstantial sex activity and furthermore, a method is provided that utilizes estrogen compounds in the absence of testosterone for treating neurodegenerative diseases including Alzheimer's disease so as to retard the adverse effects of these disorders, Examples of estrogen compounds that have insubstantial sex activity includes alpha isomers of estrogen compounds such as 17.alpha. estradiol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.